2023 Pharmacy Forecast Report
January 27, 2023
In this podcast, Dr. Francesca Cunningham, Dr. Joseph DiPiro, and Dr. Scott Nelson discuss the 2023 ASHP/ASHP Foundation Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Francesca (Fran) Cunningham, PharmD, is the Associate Chief Consultant, PBM in the Department of Veterans Affairs and the Director of the VA Center for Medication Safety (VAMedSAFE). Her program serves as VA’s comprehensive pharmacovigilance program with a major focus on drug and vaccine safety surveillance assessing the potential risks of new molecular entities or older agents with newly identified adverse events.
Joseph T. DiPiro, PharmD, is Dean, Professor and Archie. O. McCalley Chair at the Virginia Commonwealth University School of Pharmacy. He graduate of the University of Connecticut and the University of Kentucky. He served a residency at the University of Kentucky Medical Center and a fellowship in Clinical Immunology at Johns Hopkins University. He is Past-President of AACP and Past President of ACCP. He has served on the ASHP Commission on Therapeutics and the Task Force on Science, and as a past Editor of the American Journal of Pharmaceutical Education.
Scott Nelson, PharmD, MS is a pharmacist and Associate Professor in the Department of Biomedical Informatics at Vanderbilt University Medical Center. Dr. Nelson is the Director of the Master of Science in Applied Clinical Informatics (MS-ACI) online program, and currently works in Medication Safety Informatics in HealthIT, with a focus on medication reconciliation, e-prescribing, and clinical decision support at Vanderbilt University Medical Center.
ADVERTISEMENT
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.